Multiple Sclerosis News Today
Skip to content
  • Ocrevus
  • #CMSC17
  • MS Columns
    • Engaging Thoughts
    • The MS Wire
    • Faith of the Mustard Seed
    • You’ve Got Some Nerves
    • Make Change Happen
    • Patiently Awakened
    • Making a Difference
    • A Life in Letters
    • MS in Moderation
    • Fall Down, Get Up Again
    • MS in Motion – A Column by Mike Knight
  • What is MS?
    • MS Types
      • Clinically Isolated Syndrome (CIS)
      • Primary Progressive Multiple Sclerosis (PPMS)
      • Relapsing-Remitting Multiple Sclerosis (RRMS)
      • Secondary Progressive Multiple Sclerosis (SPMS)
    • Autoimmune Disease
    • Prognosis and Life Expectancy
    • MS vs. ALS: How Do They Differ?
    • Statistics
  • About MS
    • Bladder Problems and MS
    • Urinary Incontinence and MS
    • Neurogenic Detrusor Overactivity and MS
  • Symptoms
    • Early Signs
    • Fatigue
    • Flare-ups
    • Bladder Issues
      • Bladder Infection
      • Bladder Spasms
      • Neurogenic Bladder
      • Overactive Bladder
      • Urinary Retention
    • Bowel Incontinence
    • Depression
    • Pain
    • Dysesthesia
    • Heat Intolerance
    • Lhermitte’s sign
    • Sexual Dysfunctions
    • Spasticity
    • The MS hug
    • Uhthoff’s Syndrome
    • Vision Problems
      • Optic Neuritis in Multiple Sclerosis
  • Diagnosis
    • Guidelines for MS diagnosis: McDonald Criteria
    • Magnetic Resonance Imaging (MRI) and MS Diagnosis
    • Evoked Potential (EP) Test and Multiple Sclerosis Diagnosis
    • Spinal Tap Test and Multiple Sclerosis Diagnosis
  • Therapies
    • Manage MS Symptoms
      • Fatigue
        • Amantadine For Fatigue
        • Provigil (modafinil)
        • Antivert (meclizine) for Vertigo and Dizziness
        • Prozac (fluoxetine)
      • Bladder Dysfunction
        • Botox (onabotulinumtoxinA)
        • DDAVP Nasal Spray
        • Detrol (tolterodine)
        • Ditropan (oxybutynin) & Ditropan XL
        • Enablex (darifenacin)
        • Flomax (tamsulosin)
        • Hytrin (terazosin)
        • Minipress (prazosin)
        • Oxytrol (oxybutynin)
        • Propantheline
        • Sanctura (trospium chloride)
        • Tofranil (imipramine)
        • Vesicare (solifenacin succinate)
      • Bowel Dysfunction
        • Colace (docusate) for Constipation
        • Dulcolax (bisacodyl)
        • Enemeez (docusate stool softener laxative)
        • Fleet Enema (sodium phosphate) for Constipation
        • Metamucil (psyllium) for Constipation
        • Mineral Oil for Constipation
        • Phillips Milk of Magnesia (magnesium hydroxide) for Constipation
        • Sani-Supp Suppository (glycerin) for Constipation
      • Depression
        • Cymbalta (duloxetine hydrochloride) for Depression
        • Effexor XR (venlafaxine) for Depression
        • Nuedexta (dextromethorphan + quinidine) for PBA
        • Paxil (paroxetine) for Depression
        • Prozac (fluoxetine) for Depression
        • Wellbutrin (bupropion) for Depression
        • Zoloft (sertraline) for Depression
      • Infections
        • Cipro (ciprofloxacin) for UTIs
        • Hiprex (methenamine) for UTIs
        • Macrodantin (nitrofurantoin) for UTIs
      • Muscle Spasms
        • Dantrium (dantrolene)
        • Botox (onabotulinumtoxinA)
        • Gablofen (baclofen – intrathecal)
        • Klonopin – Rivotril – Syn-Clonazepam (clonazepam)
        • Lioresal (baclofen)
        • Nydrazid / Laniazid (isoniazid)
        • Valium (diazepam)
        • Zanaflex (tizanidine)
      • Pain
        • Amitriptyline for Pain Management
        • Atarax (hydroxyzine) for Itching and Burning
        • Deltasone (prednisone) for Relapse Management
        • Dilantin (phenytoin) for Pain Management
        • Klonopin (clonazepam) for Pain Management
        • Neurontin (gabapentin) for Pain Management
        • Pamelor; Aventyl (nortriptyline) for Pain Managemen
        • Pyridium (phenazopyridine) for UTI Pain
        • Tegetrol (carbamazepine) for Pain Management
      • Sexual Dysfunction
        • Cialis (tadalafil) for Erectile Dysfunction
        • Levitra (vardenafil) for Erectile Dysfunction
        • MUSE (alprostadil) for Erectile Dysfunction
        • Papaverine for Erectile Dysfunction
        • Viagra for Erectile Dysfunction & Female Sexual Arousal Disorder
    • Approved Treatments
      • AMPYRA
      • Aubagio
      • Avonex
      • Betaseron
      • Copaxone
      • Decadron
      • Extavia
      • Gilenya
      • Glatopa
      • Lemtrada
      • Novantrone
      • Ocrevus
      • Plegridy
      • Tecfidera
      • Rebif (interferon beta-1a)
      • Solu-Medrol
      • Tysabri (Natalizumab)
      • Zinbryta (Daclizumab)
    • Assistive Devices for Multiple Sclerosis
      • External Urethral Barrier
      • ReWalk for Multiple Sclerosis
      • SafeGait 360 Balance and Mobility Trainer
    • RRMS Therapies
    • Stem Cell Therapy
      • aHSCT – Autologous Hemopoietic Stem Cell Transplantation in MS
      • Different Types of Stem Cells
      • Stem Cell Clinical Trials and MS
        • Mesenchymal Stem Cell (MSCT) Clinical Trials
        • Neuron Stem Cell (NSC) Clinical Trials
      • How are Stem Cells Regulated?
    • Experimental Treatments
      • ALKS 8700
      • AP-1
      • Midamor (Amiloride) for PPMS and SPMS
      • Amiselimod (MT-1303)
      • Anti-LINGO-1 / BIIB033 / Opicinumab
      • APD334
      • ATL1102
      • ATX-MS-1467
      • BN201
      • Cladribine
      • Dalazatide (Formerly ShK-186)
      • Dysport (abobotulinumtoxin A) for Overactive Bladder
      • CTP-354
      • GIFT-15
      • GLX1112
      • GNbAC1
      • Ibudilast (MN-166)
      • IkT-001Pro
      • Laquinimod (Nerventra, ABR-215062) for PPMS
      • Lisinopril
      • Lipoic Acid
      • Masitinib (AB1010)
      • Minocycline
      • MD1003
      • MEDI-551
      • MIS416 for SPMS
      • NDC-1308
      • Ofatumumab (Arzerra)
      • Ozanimod (Formerly RPC1063)
      • PDA-001
      • Ponesimod
      • Raltegravir (isentress)
      • Raxone (Idebenone) for PPMS
      • Rituximab
      • RHB-104
      • rHIgM22
      • Riluzole for PPMS and SPMS
      • RPI-78M
      • RTL1000
      • Simvastatin for SPMS
      • Siponimod (BAF312) for SPMS
      • Tcelna
      • Vatelizumab (GBR 500)
      • Vitamin D
      • Zenapax
  • Healthy Living
    • Physical Exercise
    • Diet & Nutrition
      • Swank Diet
      • McDougall Diet
      • Paleo Diet
      • Mediterranean Diet
      • Gluten-Free Diet
      • Foods to Eat and Avoid
  • Trackers
    • RMS Therapy Tracker
    • PMS Therapy Tracker
  • Categories
    • Social Clips
    • Ocrelizumab
      • Roche Interview on Ocrelizumab
    • #CMSC16
    • #CONy16
    • ACTRIMS2016
    • ECTRIMS 2015
    • RRMS
    • SPMS
    • PPMS
    • Clinical Trials
    • National MS Society

Welcome!

September 9, 2016September 9, 2016
Michael Naceby Michael Nace

Home » Welcome!

Thank you for subscribing to our tri-weekly e-newsletter! You will now receive three e-newsletters per week — a Monday “news” newsletter, a Wednesday “columns” newsletter, and a Friday “social media” newsletter.

Read the latest news on Relapsing Multiple Sclerosis.

Join More Than 40,000 Subscribers to our Free Email Newsletters

* indicates required

Our Most Recent Posts

  • healthcare and MS

    Dialing for MS Dollars: Fighting ‘Repeal and Replace’ One Call at a Time

    July 26, 2017

  • Clinical trial approved for cell therapy

    Q Therapeutics Approved to Start Trial of Cell Therapy Aiming to Restore Myelin

    July 26, 2017

  • Canada MS trial

    Wealthy Oilman with Multiple Sclerosis Funds Canadian Studies for Promising MS Therapy

    July 26, 2017


Featured Posts

  • healthcare and MS Dialing for MS Dollars: Fighting ‘Repeal and Replace’ One Call at a Time
  • Clinical trial approved for cell therapy Q Therapeutics Approved to Start Trial of Cell Therapy Aiming to Restore Myelin
  • Canada MS trial Wealthy Oilman with Multiple Sclerosis Funds Canadian Studies for Promising MS Therapy
  • NKTR-358 for autoimmune disorders Lilly, Nektar Partner to Develop T-Cell Stimulator NKTR-358 for MS, Autoimmune Disorders

MS News

BioNews Services, LLC
5307 E. Mockingbird Ln.
5th Floor
Dallas, TX 75206
Email: [email protected]
Phone: 1-800-936-1363

BioNews Feed

Recent Posts

  • healthcare and MS

    Dialing for MS Dollars: Fighting ‘Repeal and Replace’ One Call at a Time

    July 26, 2017

  • Clinical trial approved for cell therapy

    Q Therapeutics Approved to Start Trial of Cell Therapy Aiming to Restore Myelin

    July 26, 2017

  • Canada MS trial

    Wealthy Oilman with Multiple Sclerosis Funds Canadian Studies for Promising MS Therapy

    July 26, 2017

  • NKTR-358 for autoimmune disorders

    Lilly, Nektar Partner to Develop T-Cell Stimulator NKTR-358 for MS, Autoimmune Disorders

    July 25, 2017

  • About MS News Today
  • Contact Us
  • Privacy Policy
  • Terms of Service
  • Advertise

Disclaimer:

Multiple Sclerosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
Copyright © 2013-2017 All rights reserved n